definiens: means the total cost of manufacturingLicensed Antibodies or Licensed Product, as applicable, including thefollowing components ( i ) external manufacturing fees, including freight andduty ; ( ii ) raw materials, excipients, and packaging components ; ( iii ) directlabor ; ( iv ) factory overhead costs that can be directly attributed to theLicensed Antibodies or Licensed Product, such as equipment maintenanceand repair, ongoing stability program costs, other plant services ( e.g., wastetreatment, waste incineration ), supplies, and indirect labor ( e.g., indirecthourly wages, salaried personnel, employee benefits, and overtime ), anddepreciation on direct capital assets ( capital assets that can be directlyattributed to the Licensed Antibodies or Licensed Product ) ; and ( v)allocations of indirect factory overhead and site support costs, such asutilities, quality assurance / testing, plant security, site science and technology(e.g ., process design, process improvement ), engineering, plantmanagement / administration, building maintenance and repairs, safety andenvironmental, production planning and scheduling, depreciation on indirectcapital assets, procurement, warehousing, and corporate site services ( e.g.,Finance, Human Resources, Information Services, etc . )